Home Search

bladder cancer - search results

If you're not happy with the results, please do another search
Gloved Hand Holding Urine Sample

Urine Gene Panel Test Predicts Bladder Cancer Years Before Diagnosis

A urine-based test that detects mutations in 60 genes was shown to predict bladder cancer up to 12 years before diagnosis.
NK Cell (Natural Killer Cell) Attacking a Cancer Cell

Immune Cell that Helps Kill Bladder Cancer Tumors IDed by Mount Sinai Team

Researchers report that they had found a subset of CD8 T cells in bladder cancer that adapt to tumor evasion strategies by appropriating innate-like properties traditionally ascribed to natural killer cells.
Immune checkpoint inhibitors: Interaction between PD-1 and PD-L1  blocked by therapeutic antibodies

Gene Signature Linked with Immunotherapy Response in Bladder Cancer

Investigators at the Cedars-Sinai Cancer Center have identified genetic signatures that may help predict whether tumors in patients with bladder and other cancers will respond to immunotherapy.
Bladder Cancer

Immunotherapy Reduces Bladder Cancer Recurrence

Results from the CheckMate 274 trial show that adjuvant immunotherapy with nivolumab after surgery and chemotherapy helped reduce bladder cancer recurrence in patients with urothelial cancer of the bladder.
Bladder Cancer

Chemo/Immunotherapy Response in Bladder Cancer Improved by Removing the Brake

Adding the anti-inflammatory medication celecoxib to immunotherapy and standard chemotherapy drugs appears to suppress aggressive bladder tumor growth, according to a proof-of-concept study led by investigators from Cedars-Sinai Medical Center.
Bladder Cancer

Genes Linked to Immunotherapy Resistance in Bladder Cancer Uncovered

A Mount Sinai research team has identified genotypes associated with sensitivity and resistance to cancer immunotherapy in patients with metastatic urothelial cancer of the bladder, as well a specific type of white blood cell that helps promote cancer-related inflammation in some people.
Bladder cancer, light micrograph

New Anti-PD-L1 Study Findings Support Immunotherapy for Bladder Cancer

This single-arm Phase II study investigating two cycles of atezolizumab achieved the primary efficacy endpoint, showing a pathological complete response rate of 31%.
Medical: Sterile Urine sample and blood test

Urine Better than Blood for Determining Bladder Cancer Genomic Profile

Liquid biopsy using urine is better than testing blood when it comes to accurately reflecting the genomic profile of bladder cancer tumors. That’s according...
Liquid Biopsy Test for Bladder Cancer

Liquid Biopsy Test for Bladder Cancer

MDxHealth has launched its AssureMD for Bladder Cancer test in the U.S. as a laboratory developed test (LDT).
Researchers at University Hospital of Lyon in France have developed a urine biomarker test designed to detect urothelial bladder cancer

Researchers Develop Single Biomarker Assay to Predict Bladder Cancer Recurrence

Urine biomarker test detects urothelial bladder cancer, predicts likelihood of recurrence earlier and more accurately than current methods


Inside Precision Medicine